Oracle shares declined more than 5% in the latest trading session, underperforming major benchmarks after bondholders filed a class action suit alleging the company misled investors regarding its AI spending commitments. The lawsuit claims Oracle failed to disclose material risks tied to its compute contracts, prompting several Wall Street firms to cut earnings forecasts and price targets. Analysts at two leading brokerages downgraded the stock’s outlook, citing legal uncertainties and potential financial liabilities that could weigh on free cash flow over the next 12–18 months.

In early 2026 Oracle unveiled a comprehensive capital raise designed to fund its next-generation data center and AI expansion strategy. The program targets $45–50 billion of gross proceeds via a balanced mix of debt and equity. On the equity side, the company has established a $20 billion at-the-market issuance facility calibrated to market liquidity conditions. Concurrently, it plans a one-time offering of investment-grade senior unsecured notes to cover the remaining funding requirement. Rating agencies have retained Oracle’s investment-grade status, noting its asset base of nearly $205 billion and a debt-to-equity ratio below 4.0x.

Oracle reported second-quarter cloud infrastructure revenue of $4.1 billion, up 66% year-over-year, driven in large part by accelerated GPU-linked sales that surged 177%. Backlog for capacity commitments climbed 143%, reflecting strong demand from hyperscale and enterprise AI customers. Cloud applications revenue grew 20%, supported by renewals and expansion in financial services and retail verticals. Management highlighted a multi-year pipeline of $300 billion in compute spending, underscoring the strategic importance of its autonomous data center footprint and integrated software stack.

Oracle Health secured a pilot engagement with Lumeo Regional Health Information System, a consortium of six Ontario hospitals, to deploy its Clinical AI Agent. The voice-enabled platform will auto-generate near-real-time draft clinical notes within a shared electronic health record, aiming to reduce physician documentation time by up to 30%. Oracle projects the healthcare segment to contribute over $1 billion in incremental revenue by fiscal 2027, as hospitals and payers increasingly adopt AI-driven workflows to alleviate administrative burden and enhance patient care.